Cancer screening research consortium gets €1.25m funding boost

A ground-breaking cervical screening initiative drawing together academic institutions, hospitals and biotechnology companies was granted €1.25m in funding today.

A ground-breaking cervical screening initiative drawing together academic institutions, hospitals and biotechnology companies was granted €1.25m in funding today.

The cancer research consortium, called Cerviva, has been launched to increase awareness and support for research into diseases of the cervix.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited